Odesso, the Tech Company Revolutionizing Healthcare Via GenAI

By Greg Grzesiak Greg Grzesiak has been verified by Muck Rack's editorial team
Published on October 7, 2024

“A healthy person has a thousand wishes, but a sick person has only one.” This Indian proverb shines light on the contrast between a healthy person and a sick one. Many of us have experienced moments of sickness or medical conditions where we longed to feel better, and during these times, we depend on the healthcare system. But it’s no secret that the US healthcare system is overburdened and underfunded and that it has long faced a myriad of problems that have only compounded and negatively affected patient outcomes. Solving even a few of them would drastically improve the system and, in turn, the care that patients receive. Fortunately, this has been happening quietly over the last few years, thanks to Odesso and companies like it.

Healthcare’s Silent Champion

There are many barriers to health that continue to prevent parts of the population from having access to care (an issue on its own). But when you have access, you would think all barriers would be entirely eliminated. This is far from the truth. Operational and financial issues make up the two main foundational challenges and underscore all of the ones that have stemmed as a result. There are many trade offs. For instance, you may have access but not necessarily quality of care. You can go in for a test but the results may take weeks or months to get back to you. 

Where Odesso has come in and made its mark over the last few years is on the operational side in addition to directly improving patient outcomes. Odesso has been a quiet champion for major companies within North America’s healthcare industry by helping them deliver what’s called value-based care through its AI technology.

When we think about the term patient care, we have to remember that each and every individual person experiences illness differently. The baseline challenge Odesso solves, which is complex in itself, is that it helps providers improve quality of care and their ability to serve a larger patient network in a shorter amount of time. Layering on top of this, the technology’s been designed to actually consider a host of patient’s needs.

Odesso’s History

Odesso was formed in 2017 by Zameer Rizvi, CEO, Founder and acting CTO. Originally having entered the field of tech through engineering and software automation, his time in the field led him not only to recognize the gaps but understand them. The inspiration for Zameer has come from many different sources, but the most important one is the last words his father told him before passing away from cancer: “soar as an engineer.” Zameer has taken these words to heart and they have become his guiding light in everything that he does and part of the reason why he is so focused about changing healthcare as we know it.

Where Is Odesso’s Platform Used? 

There are currently 10 major areas of healthcare where Odesso’s platform leverages GenAI to deliver better quality care:

  1. Obstetrics and Gynecology
  2. Cardiology
  3. Internal Medicine
  4. Endocrinology
  5. Ophthalmology
  6. X-Ray and CT Scan Imaging
  7. Gastroenterology
  8. Nephrology
  9. Pulmonology
  10. Rheumatology

By providing the industry with what it needs to alleviate its challenges, through technology, Odesso is empowering providers to re-shift focus from internal problems back to the reason the industry exists in the first place — to serve those in need of care, to serve patients.

By Greg Grzesiak Greg Grzesiak has been verified by Muck Rack's editorial team

Greg Grzesiak is an Entrepreneur-In-Residence and Columnist at Grit Daily. As CEO of Grzesiak Growth LLC, Greg dedicates his time to helping CEOs influencers and entrepreneurs make the appearances that will grow their following in their reach globally. Over the years he has built strong partnerships with high profile educators and influencers in Youtube and traditional finance space. Greg is a University of Florida graduate with years of experience in marketing and journalism.

Read more

More GD News